Evolution and recombination of genes encoding HIV-1 drug resistance and tropism during antiretroviral therapy

Binshan Shi, Christina Kitchen, Barbara Weiser, Douglas Mayers, Brian Foley, Kimdar Kemal, Kathryn Anastos, Marc Suchard, Monica Parker, Cheryl Brunner, Harold Burger

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Characterization of residual plasma virus during antiretroviral therapy (ART) is a high priority to improve understanding of HIV-1 pathogenesis and therapy. To understand the evolution of HIV-1 pol and env genes in viremic patients under selective pressure of ART, we performed longitudinal analyses of plasma-derived pol and env sequences from single HIV-1 genomes. We tested the hypotheses that drug resistance in pol was unrelated to changes in coreceptor usage (tropism), and that recombination played a role in evolution of viral strains. Recombinants were identified by using Bayesian and other computational methods. High-level genotypic resistance was seen in ~70% of X4 and R5 strains during ART. There was no significant association between resistance and tropism. Each patient displayed at least one recombinant encompassing env and representing a change in predicted tropism. These data suggest that, in addition to mutation, recombination can play a significant role in shaping HIV-1 evolution.

Original languageEnglish (US)
Pages (from-to)5-20
Number of pages16
JournalVirology
Volume404
Issue number1
DOIs
StatePublished - Aug 2010

Fingerprint

Tropism
Drug Resistance
Genetic Recombination
HIV-1
Genes
pol Genes
env Genes
Therapeutics
Genome
Viruses
Mutation

Keywords

  • HIV-1 drug resistance
  • HIV-1 recombination
  • HIV-1 tropism

ASJC Scopus subject areas

  • Virology

Cite this

Shi, B., Kitchen, C., Weiser, B., Mayers, D., Foley, B., Kemal, K., ... Burger, H. (2010). Evolution and recombination of genes encoding HIV-1 drug resistance and tropism during antiretroviral therapy. Virology, 404(1), 5-20. https://doi.org/10.1016/j.virol.2010.04.008

Evolution and recombination of genes encoding HIV-1 drug resistance and tropism during antiretroviral therapy. / Shi, Binshan; Kitchen, Christina; Weiser, Barbara; Mayers, Douglas; Foley, Brian; Kemal, Kimdar; Anastos, Kathryn; Suchard, Marc; Parker, Monica; Brunner, Cheryl; Burger, Harold.

In: Virology, Vol. 404, No. 1, 08.2010, p. 5-20.

Research output: Contribution to journalArticle

Shi, B, Kitchen, C, Weiser, B, Mayers, D, Foley, B, Kemal, K, Anastos, K, Suchard, M, Parker, M, Brunner, C & Burger, H 2010, 'Evolution and recombination of genes encoding HIV-1 drug resistance and tropism during antiretroviral therapy', Virology, vol. 404, no. 1, pp. 5-20. https://doi.org/10.1016/j.virol.2010.04.008
Shi, Binshan ; Kitchen, Christina ; Weiser, Barbara ; Mayers, Douglas ; Foley, Brian ; Kemal, Kimdar ; Anastos, Kathryn ; Suchard, Marc ; Parker, Monica ; Brunner, Cheryl ; Burger, Harold. / Evolution and recombination of genes encoding HIV-1 drug resistance and tropism during antiretroviral therapy. In: Virology. 2010 ; Vol. 404, No. 1. pp. 5-20.
@article{b8320a3328624077a69d388c1c26b350,
title = "Evolution and recombination of genes encoding HIV-1 drug resistance and tropism during antiretroviral therapy",
abstract = "Characterization of residual plasma virus during antiretroviral therapy (ART) is a high priority to improve understanding of HIV-1 pathogenesis and therapy. To understand the evolution of HIV-1 pol and env genes in viremic patients under selective pressure of ART, we performed longitudinal analyses of plasma-derived pol and env sequences from single HIV-1 genomes. We tested the hypotheses that drug resistance in pol was unrelated to changes in coreceptor usage (tropism), and that recombination played a role in evolution of viral strains. Recombinants were identified by using Bayesian and other computational methods. High-level genotypic resistance was seen in ~70{\%} of X4 and R5 strains during ART. There was no significant association between resistance and tropism. Each patient displayed at least one recombinant encompassing env and representing a change in predicted tropism. These data suggest that, in addition to mutation, recombination can play a significant role in shaping HIV-1 evolution.",
keywords = "HIV-1 drug resistance, HIV-1 recombination, HIV-1 tropism",
author = "Binshan Shi and Christina Kitchen and Barbara Weiser and Douglas Mayers and Brian Foley and Kimdar Kemal and Kathryn Anastos and Marc Suchard and Monica Parker and Cheryl Brunner and Harold Burger",
year = "2010",
month = "8",
doi = "10.1016/j.virol.2010.04.008",
language = "English (US)",
volume = "404",
pages = "5--20",
journal = "Virology",
issn = "0042-6822",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Evolution and recombination of genes encoding HIV-1 drug resistance and tropism during antiretroviral therapy

AU - Shi, Binshan

AU - Kitchen, Christina

AU - Weiser, Barbara

AU - Mayers, Douglas

AU - Foley, Brian

AU - Kemal, Kimdar

AU - Anastos, Kathryn

AU - Suchard, Marc

AU - Parker, Monica

AU - Brunner, Cheryl

AU - Burger, Harold

PY - 2010/8

Y1 - 2010/8

N2 - Characterization of residual plasma virus during antiretroviral therapy (ART) is a high priority to improve understanding of HIV-1 pathogenesis and therapy. To understand the evolution of HIV-1 pol and env genes in viremic patients under selective pressure of ART, we performed longitudinal analyses of plasma-derived pol and env sequences from single HIV-1 genomes. We tested the hypotheses that drug resistance in pol was unrelated to changes in coreceptor usage (tropism), and that recombination played a role in evolution of viral strains. Recombinants were identified by using Bayesian and other computational methods. High-level genotypic resistance was seen in ~70% of X4 and R5 strains during ART. There was no significant association between resistance and tropism. Each patient displayed at least one recombinant encompassing env and representing a change in predicted tropism. These data suggest that, in addition to mutation, recombination can play a significant role in shaping HIV-1 evolution.

AB - Characterization of residual plasma virus during antiretroviral therapy (ART) is a high priority to improve understanding of HIV-1 pathogenesis and therapy. To understand the evolution of HIV-1 pol and env genes in viremic patients under selective pressure of ART, we performed longitudinal analyses of plasma-derived pol and env sequences from single HIV-1 genomes. We tested the hypotheses that drug resistance in pol was unrelated to changes in coreceptor usage (tropism), and that recombination played a role in evolution of viral strains. Recombinants were identified by using Bayesian and other computational methods. High-level genotypic resistance was seen in ~70% of X4 and R5 strains during ART. There was no significant association between resistance and tropism. Each patient displayed at least one recombinant encompassing env and representing a change in predicted tropism. These data suggest that, in addition to mutation, recombination can play a significant role in shaping HIV-1 evolution.

KW - HIV-1 drug resistance

KW - HIV-1 recombination

KW - HIV-1 tropism

UR - http://www.scopus.com/inward/record.url?scp=77953708340&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953708340&partnerID=8YFLogxK

U2 - 10.1016/j.virol.2010.04.008

DO - 10.1016/j.virol.2010.04.008

M3 - Article

VL - 404

SP - 5

EP - 20

JO - Virology

JF - Virology

SN - 0042-6822

IS - 1

ER -